LCT-MCT8 was the only KD that produced significant suppression of tumor growth in SK-N-BE(2) xenografts from day 12 till the end of the intervention (Figure 1B), albeit the effect was much less pronounced than the growth suppression on the SH-SY5Y xenografts. Here, SLC16A2 is linked to neoplasm.